ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 708559 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 708559; 2) Community: the network communities that were significantly associated with the response to NSC 708559; 3) Molecule: the relationships between components within communities and NSC 708559; 4) MDR: the compounds that were significantly associated with the NSC 708559.

NSC Compound Enrichment Correlation
NSC 727286 6-(bromomethyl)-1,4-anthracenedione. 0.0430505868034758 -0.020329686
NSC 753376 3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1-methyl-1H-indole 0.0430505868034758 -0.13319117
NSC 105827 SANGIVAMYCIN,-THIO 0.0430505868034761 0.13607159
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0430505868034761 0.25042531
NSC 149765 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) 0.0430505868034761 0.33838944
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0430505868034761 0.092195596
NSC 176323 Camptothecin Derivative 0.0430505868034761 -0.083398369
NSC 201873 Null 0.0430505868034761 0.14965221
NSC 208885 Null 0.0430505868034761 0.23561858
NSC 228120 Benzofurazan, 4-[(3-methoxyphenyl)thio]-7-nitro-, 3-oxide 0.0430505868034761 0.022089137
Total:82  Current:70    [First] [Prev] [Next] [Last]